The company’s survey closed in September 2018. Johnson & Johnson maintains a significant lead on market share; however, Zimmer Biomet and Stryker are closing the gap.
1. Johnson & Johnson had 21.8 percent market share in 2017 and is expected to have 24.2 percent in 2024.
2. Zimmer Biomet had 18.8 percent market share in 2017 and is expected to have 20.3 percent in 2024.
3. Stryker had 18 percent market share in 2017 and is expected to have 16.3 percent in 2024.
4. Medtronic had 8 percent market share in 2017 and is expected to have 8.3 percent in 2024.
5. Arthrex had 6 percent market share in 2017 and is expected to have the same, 5.8 percent, in 2024.
6. Smith & Nephew had 5.4 percent market share in 2017 and is expected to have 5.7 percent in 2024.
7. Wright Medical Group had 3 percent market share in 2017 and is expected to have 2 percent in 2024.
8. NuVasive had 2.3 percent market share in 2017 and is expected to have 1.7 percent in 2024.
9. Globus Medical had 2.3 percent market share in 2017 and is expected to have 2 percent in 2024.
10. Orthofix had 1.3 percent market share in 2017 and is expected to have 1.2 percent in 2024.
More articles on orthopedics:
Where spine reimbursement is headed—Key thoughts from 4 spine surgeons
19 spine devices receive FDA 510(k) clearance
Orthopedic diagnostics company closes $18.3M funding round: 3 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.